Executive record

Sahil Kirpekar, M.D.

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:sahil-kirpekar-m-dVersion: public-0As of: 2026-09-28

Not yet claimed6 published Claims1 sources

Key Claims

Biography

Chief Business Officer since November 2022 (ceased April 2, 2025). Previously Head of Business Development at Otsuka Pharmaceutical and strategy consultant at Double Helix Consulting/McCann Health. Trained physician with MPhil from University of Cambridge.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2025 to end not publishedExecutive title: Chief Business Officer · Organization not publishedATAI DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ATAI DEF 14A executive officers

    sec filing · Source published: Apr 21, 2025 · Retrieved: May 15, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Atai Beckley N.V. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Business Officer · Claim reviewed: May 15, 2026
    • Other Company Role: Sahil Kirpekar, M.D. is also linked to IntelGenx Technologies Corp. as Board of Directors. · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026